Role of p16/MTS1, cyclin D1 and RB in primary oral cancer and oral cancer cell lines

British Journal of Cancer

Volumn 80, Issue 1-2, 1999, Pages 79-86

  Sartor, M ^a   Steingrimsdottir, H ^a   Elamin, F ^a   Gaken J ^a   Warnakulasuriya, S ^a   Partridge, M ^a   Thakker, N ^b   Johnson, N W ^a   Tavassoli, M ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b ST MARY S HOSPITAL   (United Kingdom)

Author keywords

Cyclin D1; G1 checkpoint; Oral cancer; p16 MTS1; Retinoblastoma

Indexed keywords

CYCLIN D1; PROTEIN P16; RETINOBLASTOMA PROTEIN;

ADULT; AGED; ARTICLE; CARCINOGENESIS; CELL LINE; CLINICAL ARTICLE; CODON; FEMALE; FRAMESHIFT MUTATION; GENE CONTROL; GENE DELETION; GENE EXPRESSION; GENE MUTATION; GENE OVEREXPRESSION; HUMAN; IMMUNOBLOTTING; MALE; MOUTH CANCER; POINT MUTATION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SQUAMOUS CELL CARCINOMA;

EID: 0032895884     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6690505     Document Type: Article

References (70)

1. Andl T, Kahn T, Pfuhl A, Nicola T, Erber R, Conradt C, Klein W, Helbig M, Dietz A, Weidauer H, and Bosch FX (1998) Etiological involvement of oncogenic human papillomavirus in tonsillar squamous cell carcinomas lacking retinoblastoma cell cycle control. Cancer Res 58: 5-13
2. Arap W, Knudsen ES, Wang JY, Cavenee WK and Huang HJ (1997) Point muatations can inactivate in vitro and in vivo activities of p16 (INK4a) /CDKN2A in human glioma. Oncogene 14: 603-609
3. Bagehi S, Weinmann R and Raychaudhuri P (1991) The retinoblastoma protein copurifies with E2F-I, an E1A-regulated inhibitor of the transcription factor E2F. Cell 65: 1063-1072
4. Bartkova J, Lukas J, Muller H, Strauss M, Gusterson B and Bartek J (1995a) Abnormal patterns of D-type cyclin expression and G1 regulation in human head and neck cancer. Cancer Res 55: 949-956
5. Bartkova J, Lukas J, Strauss M and Bartek J (1995b) Cyclin D1 oncoprotein aberrantly accumulates in malignancies of diverse histogenesis. Oncogene 10: 775-778
6. Berenson JR, Yang J and Mickel RA (1989) Frequent amplification of the bel-1 locus in head and neck squamous cell carcinomas. Oncogene 4: 1111-1116
7. Chellappan SP, Hiebert S, Mudryj M, Horowitz JM and Nevins JR (1991) The E2F transcription factor is a cellular target for the RB protein. Cell 55: 1053-1061
8. Chen PL, Scully P, Shew JY, Wang JY and Lee WH (1989) Phosphorylation of the retinoblastoma gene product is modulated during the cell cycle and cellular differentiation. Cell 55: 1193-1198
9. Cheng JQ, Jhanwar SC, Klein WM, Bell DW, Lee WC, Altomare DA, Nobori T, Olopade OI, Buckler AJ and Testa JR (1994) p16 alterations and deletion mapping of 9p21-p22 in malignant mesothelioma. Cancer Res 54: 5547-5551
10. Elamin F, Steingrimsdottir H, Warnakulasuriya S, Johnson NW and Tavassoli M (1998) Prevalence of human papillomavirus infection in premalignant and malignant lesions of the oral cavity in U.K. subjects: A novel method of detection. Eur J Cancer 34: 191-197
11. Ewen ME, Sluss HK, Sherr CJ, Matsushime H, Kato J and Livingston DM (1993) Functional interactions of the retinoblastoma protein with mammalian D-type cyclins. Cell 73: 487-497
12. Farrell WE, Simpson DJ, Bicknell JE, Talbot AJ, Bates AS and Clayton RN (1997) Chromosome 9p deletions in invasive and noninvasive nonfunctional pituitary adenomas: the deleted region involves markers outside of the MTS1 and MTS2 genes. Cancer Res 57: 2703-2709
13. Fountain JW, Karayiorgou M, Ernstoff MS, Kirkwood JM, Vlock DR, Titus Ernstoff L, Bouchard B, Vijayasaradhi S, Houghton AN, Lahti J, Kidd VJ, Housman DE and Dracopoli NC (1992) Homozygous deletions within human chromosome band 9p21 in melanoma. Proc Natl Acad Sci USA 89: 10557-10561
14. Gonzalez-Zulueta M, Bender CM, Yang AS, Nguyen T, Beart RW, Van Tornout JM and Jones PA (1995) Methylation of the 5′ CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing. Cancer Res 55: 4531-4535
15. Goodrich DW and Lee WH (1993) Molecular characterization of the retinoblastoma susceptibility gene. Biochim Biophys Acta 1155: 43-61
16. Hagemeier C, Caswell R, Hayhurst G, Sinclair J and Kouzarides T (1994) Functional interaction between the HCMV IE2 transactivator and the retinoblastoma protein. EMBO J 13: 2897-2903
17. Hannon GJ, and Beach D (1994) p15INK4B is a potential effector of TGF-beta-induced cell cycle arrest [see comments]. Nature 371: 257-261
18. Hara E, Smith R, Parry D, Tahara H, Stone S and Peters G (1996) Regulation of p16 (CDKN2) expression and its implications for cell immortalization and senescence. Mol Cell Biol 16: 859-867
19. Hunter T and Pines J (1994) Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age [see comments]. Cell 79: 573-582
20. Jiang W, Kahn SM, Zhou P, Zhang YJ, Cacace AM, Infante AS, Doi S, Santella RM and Weinstein IB (1993) Overexpression of cyclin D1 in rat fibroblasts causes abnormalities in growth control, cell cycle progression and gene expression. Oncogene 8: 3447-3457
21. Johnson NW (1991) A global view of the epidemiology of oral cancer. In Oral Cancer, Johnson NW (ed), pp. 3-26 Cambridge University Press: Cambridge
22. Kamb A, Gruis NA, Weaver Feldhaus J, Liu Q, Harshman K, Tavtigian SV, Stockert E, Day RS III, Johnson BE and Skolnick MH (1994) A cell cycle regulator potentially involved in genesis of many tumor types [see comments]. Science 264: 436-440
23. ARF. Cell 91: 649-659
24. Koh J, Enders GH, Dynlacht BD and Harlow E (1995) Tumour-derived p16 alleles encoding proteins defective in cell-cycle inhibition. Nature 375: 506-510
25. Kyomoto R, Kumazawa H, Toda Y, Sakaida N, Okamura A, Iwanaga M, Shintaku M, Yamashita T, Hiai H and Fukumoto M (1997) Cyclin-D1-gene amplification is a more potent prognostic factor than its protein over-expression in human head-and-neck squamous-cell carcinoma. Int J Cancer 74: 576-581
26. Kyritsis AP, Zhang B, Zhang W, Xiao M, Takeshima H, Bondy ML, Cunningham JE, Levin VA and Bruner J (1996) Mutations of the p16 gene in gliomas. Oncogene 12: 63-67
27. Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685
28. Li Y, Graham C, Lacy S, Duncan AM and Whyte P (1993) The adenovirus E1A-associated 130-kD protein is encoded by a member of the retinoblastoma gene family and physically interacts with cyclins A and E. Genes Dev 7: 2366-2377
29. Liu Q, Neuhausen S, McClure M, Frye C, Weaver Feldhaus J, Gruis NA, Eddington K, Allalunis Turner MJ, Skolnick MH and Fujimura FK (1995) CDKN2 (MTS1) tumor suppressor gene mutations in human tumor cell lines. Oncogene 11: 2455
30. Lukas J, Parry D, Agard L, Mann DJ, Bartkova J, Strauss M, Peters G, and Bartek J (1995) Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16. Nature 375: 503-506
31. Martin K, Trouche D, Hagemeier C, Sorensen TS, La Thangue NB and Kouzarides T (1995) Stimulation of E2F/DP1 transcriptional activity by MDM2 oncoprotein. Nature 375: 691-694
32. Mayol X, Grana X, Baldi A, Sang N, Hu Q and Giordano A (1993) Cloning of a new member of the retinoblastoma gene family (pRb2) which binds to the E1A transforming domain. Oncogene 8: 2561-2566
33. Medema RH, Herrera RE, Lam F and Weinberg RA (1995) Growth suppression by p16ink4 requires functional retinoblastoma protein. Proc Natl Acad Sci USA 92: 6289-6293
34. Mori T, Miura K, Aoki T, Nishihira T, Mori S and Nakamura Y (1994) Frequent somatic mutation of the MTS1/CDK41 (multiple tumor suppressor/cyclin-dependent kinase 4 inhibitor) gene in esophageal squamous cell carcinoma. Cancer Res 54: 3396-3397
35. Ohtsubo M and Roberts JM (1993) Cyclin-dependent regulation of G1 in mammalian fibroblasts. Science 259: 1908-1912
36. Olshan AF, Weissler MC, Pei H, Conway K, Anderson S, Fried DB and Yarbrough WG (1997) Alterations of the p16 gene in head and neck cancer: frequency and association with p53, PRAD-1 and HPV. Oncogene 14: 811-818
37. Otterson GA, Khleif SN, Chen W, Coxon AB and Kaye FJ (1995) CDKN2 gene silencing in lung cancer by DNA hypermethylation and kinetics of p16INK4 protein induction by 5-aza 2′ deoxycytidine. Oncogene 11: 1211-1216
38. Papadimitrakopoulou V, Izzo J, Lippman SM, Lee JS, Fan YH, Clayman G, Ro JY, Hittelman WN, Lotan R, Hong WK and Mao L (1997) Frequent inactivation of p16INK4a in oral premalignant lesions. Oncogene 14: 1799-1803
39. Parry D, Bates S, Mann DJ and Peters G (1995) Lack of cyclin D-Cdk complexes in Rb-negative cells correlates with high levels of p16INK4/MTS1 tumour suppressor gene product. EMBO J 14: 503-511
40. Patel V, Jakus J, Harris CM, Ensley JF, Robbins KC and Yeudall WA (1997) Altered expression and activity of G1/S cyclins and cyclin-dependent kinases characterize squamous cell carcinomas of the head and neck. Int J Cancer 73: 551-555
41. Pomerantz J, Schreiber Agus N, Liegeois NJ, Silverman A, Alland L, Chin L, Potes J, Chen K, Orlow I, Lee HW, Cordon Cardo C and Depinho RA (1998) The Ink4a tumor suppressor gene product. p19Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53. Cell 92: 713-723
42. Quelle DE, Zindy F, Ashmun RA and Sherr CJ (1995) Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest. Cell 83: 993-1000
43. Quelle DE Cheng M, Ashmun RA and Sherr CJ (1997) Cancer-associated mutations at the INK4a locus cancel cell cycle arrest by p16INK4a but not by the alternative reading frame protein p19ARF. Proc Natl Acad Sci USA 94: 669-673
44. Reed AL, Califano J, Cairns P, Westra WH, Jones RM, Koch W, Ahrendt S, Eby Y, Sewell D, Nawroz H, Bartek J and Sidransky D (1996) High frequency of p16 (CDKN2/MTS-1/INK4A) inactivation in head and neck squamous cell carcinoma. Cancer Res 56: 3630-3633
45. Ruas M and Peters G (1998) The p16/INK4a/CDKN2A tumor suppressor and its relatives. Biochim Biophys Acta 1378: 115-177
46. Serrano M, Hannon GJ and Beach D (1993) A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4 [see comments]. Nature 366: 704-707
47. Serrano M, Lee H, Chin L, Cordon-Cardo C, Beach D and Depinho RA (1996) Role of the INK4a locus in tumour suppression and cell mortality. Cell 85: 27-37
48. Shapiro GI, Park JE, Edwards CD, Mao L, Merlo A, Sidransky D, Ewen ME and Rollins BJ (1995) Multiple mechanisms of p16INK4A inactivation in non-small cell lung cancer cell lines. Cancer Res 55: 6200-6209
49. Sherr CJ (1994) G1 phase progression: cycling on cue [see comments]. Cell 79: 551-555
50. Smith CJ and Pindborg JJ (1969) Histological Grading of Oral Epithelial Atypia by the Use of Photographic Standards. C Hamburgers Bogtrykkeri: Copenhagen
51. Steingrimsdottir H, Penhallow J, Farzeneh F, Johnson N and Tavassoli M (1997) Detection of p53 mutations in oral cancer samples using a sensitive PCR-based method. DNA Damage Mutagenesis 25: 315-318
52. Stone S, Jiang P, Dayananth P, Tavtigian SV, Katcher H, Parry D, Peters G and Kamh A (1995) Complex structure and regulation or the P16 (MTS1) locus. Cancer Res 55: 2988-2994
53. Suzuki T, Kitao S, Matsushime H and Yoshida M (1996) HTLV-1 Tax protein interacts with cyclin-dependent kinase inhibitor p16INK4A and counteracts its inhibitory activity towards CDK4. EMBO J 15: 1607-1614
54. Tam SW, Shay JW and Pagano M (1994) Differential expression and cell cycle regulation of the cyclin-dependent kinase 4 inhibitor p16Ink4. Cancer Res 54: 5816-5820
55. Timmermann S, Hinds PW and Munger K (1997) Elevated activity of cyclin-dependent kinase 6 in human squamous cell carcinoma lines. Cell Growth Differ 8: 361-370
56. Towbin H, Stachelin T and Gordon J (1992) Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. 1979 [classical article]. Biotechnology 24: 145-149
57. Van Der Riet P, Nawroz H, Hruban RH, Corio R, Tokino K, Koch W and Sidransky D (1994) Frequent loss of chromosome 9p21-22 early in head and neck cancer progression. Cancer Res 54: 1156-1158
58. Wang HG, Draetta G and Moran E (1991) E1A induces phosphorylation of the retinoblastoma protein independently of direct physical association between the E1A and retinoblastoma products. Mol Cell Biol 11: 4253-4265
59. Weinberg RA (1995) The retinoblastoma protein and cell cycle control. Cell 81: 323-330
60. Welcker M, Lukas J, Strauss M and Bartek J (1996) Enhanced protein stability: a novel mechanism of D-type cyclin over-abundance identified in human sarcoma cells. Oncogene 13: 419-425
61. Wong DT, Todd R, Tsuji T and Donoff RB (1996) Molecular biology of human oral cancer. Crit Rev Oral Biol Med 7: 319-328
62. Xiao ZX, Chen J, Levine AJ, Modjtahedi N, Xing J, Sellers WR and Livingston DM (1995) Interaction between the retinoblastoma protein and the oncoprotein MDM2. Nature 375: 694-697
63. Xiong Y, Hannon GJ, Zhang H, Casso D, Kobayashi R and Beach D (1993) p21 is a universal inhibitor of cyclin kinases [see comments]. Nature 366: 701-704
64. Yeudall WA, Paterson IC, Patel V and Prime SS (1995) Presence of human papillomavirus sequences in tumour-derived human oral keratinocytes expressing mutant p53. Eur J Cancer B Oral Oncol 31B: 136-143
65. Yoo GH, Xu HJ, Brennan JA, Westra W, Hruban RH, Koch W, Benedict WF and Sidransky D (1994) Infrequent inactivation of the retinoblastoma gene despite frequent loss of chromosome 13q in head and neck squamous cell carcinoma. Cancer Res 54: 4603-4606
66. Yoshida S, Todoroki T, Ichikawa Y, Hanai S, Suzuki H, Hori M, Fukao K, Miwa M and Uchida K (1995) Mutations of p16Ink4/CDKN2 and p15Ink4B/MTS2 genes in biliary tract cancers. Cancer Res 55: 2756-2760
67. Zhang SY, Klein Szanto AJ, Sauter ER, Shafarenko M, Mitsunaga S, Nobori T, Carson DA, Ridge JA and Goodrow TL (1994) Higher frequency of alterations in the p16/CDKN2 gene in squamous cell carcinoma cell lines than in primary tumors of the head and neck. Cancer Res 54: 5050-5053
68. Zhang Y, Xiong Y and Yarbrough WG (1998) ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways. Cell 92: 725-734
69. Zhou P, Jiang W, Weghorst CM and Weinstein IB (1996) Overexpression of cyclin D1 enhances gene amplification. Cancer Res 56: 36-39
70. Zhou X, Tarmin L, Yin J, Jiang HY, Suzuki H, Rhyu MG, Abraham JM and Meltzer SJ (1994) The MTS1 gene is frequently mutated in primary human esophageal tumors. Oncogene 9: 3737-3741